TG Therapeutics Inc (TGTX)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands 244,429 244,158 102,537 101,326 100,118 98,908 97,700 96,503 71,135 71,135 68,947 67,249 66,788 — — — 7,716 15,074 22,233 29,201
Total assets US$ in thousands 577,690 586,014 401,207 373,323 329,587 331,067 220,854 197,358 193,572 217,891 251,666 303,028 379,629 409,687 481,400 548,699 625,642 273,856 294,621 101,849
Debt-to-assets ratio 0.42 0.42 0.26 0.27 0.30 0.30 0.44 0.49 0.37 0.33 0.27 0.22 0.18 0.00 0.00 0.00 0.01 0.06 0.08 0.29

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $244,429K ÷ $577,690K
= 0.42

The debt-to-assets ratio of TG Therapeutics Inc has shown fluctuation over the period from March 31, 2020, to December 31, 2024. The ratio has decreased significantly from 0.29 on March 31, 2020, to 0.00 by March 31, 2021, indicating a strong reduction in debt relative to total assets. However, the ratio started to increase again from 0.18 on December 31, 2021, reaching a peak of 0.49 on March 31, 2023. This suggests that the company's level of debt relative to its total assets increased substantially during this period.

Subsequently, the ratio decreased to 0.26 on June 30, 2024, before rising again to 0.42 by December 31, 2024. Overall, the trend shows some variability in the debt-to-assets ratio, indicating changes in the company's capital structure and financial leverage. It would be important to further analyze the reasons behind these fluctuations and assess the implications for the company's financial health and risk management strategies.